Events

Avis De Sécurité sur NIM-ECLIPSE® System

Selon Ministry of Health, State Institute for Drug Control, Coordination Center for Departmental Medical Information Systems, ce/cet/cette avis de sécurité concerne un dispositif en/au/aux/à Czechia qui a été fabriqué par Medtronic Xomed.

Qu'est-ce que c'est?

Les avis de sécurité sont des communications que les fabricants de dispositifs médicaux ou leurs représentants font parvenir en particulier aux travailleurs du secteur médical, mais aussi aux utilisateurs de ces dispositifs. Les avis de sécurité concernent les actions entreprises quant aux dispositifs présents sur le marché et peuvent inclure des rappels et des alertes.

En savoir plus sur les données ici
  • Type d'événement
    Field Safety Notice
  • ID de l'événement
    1384
  • Date
    2017-12-21
  • Pays de l'événement
    Czechia
  • Source de l'événement
    MHSIDCCCDMIS
  • URL de la source de l'événement
    https://eregpublicsecure.ksrzis.cz/Registr/RZPRO/FSN
  • Notes / Alertes
    Czech data is current through July 2018. All of the data comes from the Czech Public Registry of Medical Devices, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and the Czech Republic.
  • Notes supplémentaires dans les données

Device

NIM-ECLIPSE® System
  • Modèle / numéro de série
    Model Number: NIM Eclipse® System: NWCPUE4, NCCPUE4, NCCPU, NWCPU Single-use Stimulator Probes: BNP2001, BNP2002, CNP2001, CNP2002, FTP1001, MNP1001, PSP1000, PSP1001, PSP1002, FTP2001, MNP2001, PSP2000, PSP2001, PSP2002
  • Description du dispositif
    Electromechanical medical devices
  • Manufacturer
    Medtronic Xomed

Manufacturer

Medtronic Xomed
  • Société-mère du fabricant (2017)
    Medtronic plc
  • Commentaire du fabricant
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Source
    MHSIDCCCDMIS